Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Toshiaki Iba and Jecko Thachil.
Connection Strength

11.623
  1. The authors reply. Crit Care Med. 2020 11; 48(11):e1160-e1161.
    View in: PubMed
    Score: 0.911
  2. The authors reply. Crit Care Med. 2020 10; 48(10):e989-e990.
    View in: PubMed
    Score: 0.906
  3. Coagulopathy of Coronavirus Disease 2019. Crit Care Med. 2020 09; 48(9):1358-1364.
    View in: PubMed
    Score: 0.901
  4. Coagulopathy in COVID-19. J Thromb Haemost. 2020 09; 18(9):2103-2109.
    View in: PubMed
    Score: 0.893
  5. DOACs and "newer" hemophilia therapies in COVID-19: Reply. J Thromb Haemost. 2020 07; 18(7):1795-1796.
    View in: PubMed
    Score: 0.890
  6. Laboratory haemostasis monitoring in COVID-19. J Thromb Haemost. 2020 08; 18(8):2058-2060.
    View in: PubMed
    Score: 0.881
  7. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020 05; 18(5):1023-1026.
    View in: PubMed
    Score: 0.879
  8. Newly Proposed Sepsis-Induced Coagulopathy Precedes International Society on Thrombosis and Haemostasis Overt-Disseminated Intravascular Coagulation and Predicts High Mortality. J Intensive Care Med. 2020 Jul; 35(7):643-649.
    View in: PubMed
    Score: 0.766
  9. New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey. BMJ Open. 2017 Sep 27; 7(9):e017046.
    View in: PubMed
    Score: 0.735
  10. Clinical significance of measuring plasminogen activator inhibitor-1 in sepsis. J Intensive Care. 2017; 5:56.
    View in: PubMed
    Score: 0.732
  11. The Comparison of the Protective Effects of a- and ß-Antithrombin against Vascular Endothelial Cell Damage Induced by Histone in Vitro. TH Open. 2017 Jun; 1(1):e3-e10.
    View in: PubMed
    Score: 0.722
  12. The application of anticoagulant therapy to sepsis. J Intensive Care. 2017; 5:32.
    View in: PubMed
    Score: 0.719
  13. Managing thrombosis and cardiovascular complications of COVID-19: answering the questions in COVID-19-associated coagulopathy. Expert Rev Respir Med. 2021 08; 15(8):1003-1011.
    View in: PubMed
    Score: 0.234
  14. Proposal of the Definition for COVID-19-Associated Coagulopathy. J Clin Med. 2021 Jan 07; 10(2).
    View in: PubMed
    Score: 0.231
  15. ISTH DIC subcommittee communication on anticoagulation in COVID-19. J Thromb Haemost. 2020 09; 18(9):2138-2144.
    View in: PubMed
    Score: 0.225
  16. The unique characteristics of COVID-19 coagulopathy. Crit Care. 2020 06 18; 24(1):360.
    View in: PubMed
    Score: 0.222
  17. Type and dose of heparin in Covid-19: Reply. J Thromb Haemost. 2020 08; 18(8):2063-2064.
    View in: PubMed
    Score: 0.220
  18. Proposal of a two-step process for the diagnosis of sepsis-induced disseminated intravascular coagulation. J Thromb Haemost. 2019 08; 17(8):1265-1268.
    View in: PubMed
    Score: 0.207
  19. A Proposal of the Modification of Japanese Society on Thrombosis and Hemostasis (JSTH) Disseminated Intravascular Coagulation (DIC) Diagnostic Criteria for Sepsis-Associated DIC. Clin Appl Thromb Hemost. 2018 Apr; 24(3):439-445.
    View in: PubMed
    Score: 0.182
  20. COVID-19 coagulopathy in pregnancy: Critical review, preliminary recommendations, and ISTH registry-Communication from the ISTH SSC for Women's Health. J Thromb Haemost. 2020 Nov; 18(11):3086-3098.
    View in: PubMed
    Score: 0.057
  21. Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020 Aug; 18(8):1859-1865.
    View in: PubMed
    Score: 0.056
  22. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020 06; 7(6):e438-e440.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.